ArticleAddiction (Abingdon, England)2021
Is Cannabis being used as a substitute for non-medical opioids by adults with problem substance use in the United States? A within-person analysis.
Article in Addiction (Abingdon, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.
- Association between state cannabis laws and opioid outcomes: A systematic review.Drug and alcohol dependence · 2026Pooled it
- Self-reported cannabis use to manage opioid withdrawal symptoms and reductions in opioid use among people who use unregulated opioids: a cross-sectional analysis.Journal of cannabis research · 2026Article
- The association between state cannabis legalization and non-fatal opioid poisonings among adults with employer-sponsored insurance in the United States.Preventive medicine reports · 2026Article
- Cannabis Legalization and Opioid Use Disorder in Veterans Health Administration Patients.JAMA health forum · 2025Article
- Association Between Legal Access to Medical Cannabis and Frequency of Non-Medical Prescription Opioid Use Among U.S. Adults.International journal of mental health and addiction · 2025Article
- Leveraging voice biomarkers to quantify chronic pain: a rapid review.Frontiers in pain research (Lausanne, Switzerland) · 2025Review
- Self-Reported Substance Use With Clinician Interviewers Versus Self-Administered Surveys.Journal of studies on alcohol and drugs · 2024Article
- Impact of Recreational Cannabis Legalization on Opioid Prescribing and Opioid-Related Hospital Visits in Colorado: an Observational Study.Journal of general internal medicine · 2023Observational
- Effects of U.S. State Medical Cannabis Laws on Treatment of Chronic Noncancer Pain.Annals of internal medicine · 2023Article
- Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use.Journal of psychiatric research · 2022Article
- Prevalence and correlates of cannabis use for medicinal reasons - An Australian cross-sectional study.Addictive behaviors reports · 2022Article
- Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.Substance abuse treatment, prevention, and policy · 2022Article
- Effects of combined THC and heroin vapor inhalation in rats.Psychopharmacology · 2022Article
- Validity of the DSM-5 tobacco use disorder diagnostics in adults with problematic substance use.Drug and alcohol dependence · 2022Article
- Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States.Substance abuse · 2022Article
- Illegal drug market responses to state recreational cannabis laws.Addiction (Abingdon, England) · 2021Article
- Article
- Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review.Journal of clinical medicine · 2020Review
- Cannabinoid hyperemesis syndrome: the conundrum is here to stay.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
BACKGROUND AND
aimsEcological studies have suggested that Cannabis legalization might have led to a decrease in opioid overdose deaths. Such studies do not provide information about whether individuals are substituting Cannabis for opioids at different points in time. The current study assessed the magnitude of the daily association between Cannabis and opioid use in individual adults with and without pain who use non-medical opioids.
designProspective cohort study.
settingThe greater New York area and a suburban inpatient addiction program.
participantsAdults with problem substance use who use non-medical opioids, recruited from May 2016-June 2019. The analytical sample included 13 271 days of observation among 211 participants (64% male, 41% white, 78% unmarried, 80% unemployed, mean age 43 years). MEASUREMENTS: Participants completed interviewer- and self-administered computerized surveys, and then responded to an interactive voice response (IVR) system daily for the following 90 days. The main exposures, Cannabis use and pain, were defined as responding affirmatively to the IVR question: 'Did you use Cannabis yesterday?' and endorsing moderate or severe pain at baseline, respectively. The main outcome, non-medical or illicit opioid use during 90-day follow-up, was defined as responding affirmatively to IVR question: 'Did you use heroin yesterday?' or 'Did you use prescription opioids more than prescribed or without a prescription yesterday?'.
findingsThe mean IVR completion rate was 70%. The unadjusted odds ratio (aOR) indicating same-day use of Cannabis and opioids was 2.00 [95% confidence interval (CI) = 1.54-2.59]. Controlling for demographic characteristics, recruitment method, opioid types at baseline and pain, the aOR was 1.86 (95% CI = 1.44-2.41). A test of interaction between pain and Cannabis use to determine if the association of Cannabis with opioid use differed between people with moderate-to-severe pain and less-than-moderate pain was inconclusive.
conclusionsAmong US adults with problem substance use who use non-medical opioids, the odds of opioid use appear to be approximately doubled on days when Cannabis is used. This relationship does not appear to differ between people with moderate or more severe pain versus less than moderate pain, suggesting that Cannabis is not being used as a substitute for illegal opioids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.